Expression of BUB1 protein in gastric cancer correlates with the histological subtype, but not with DNA ploidy or microsatellite instability
- PMID: 14743503
- DOI: 10.1002/path.1499
Expression of BUB1 protein in gastric cancer correlates with the histological subtype, but not with DNA ploidy or microsatellite instability
Abstract
During mitosis, the spindle checkpoint delays the onset of anaphase until all chromosomes have attached properly to the mitotic spindle, preventing chromosome missegregation. BUB (budding uninhibited by benzimidazole) 1 is one of the key components of this checkpoint. BUB1 mutations are rare in cancer tissues and no mutations have been identified in gastric cancer. In mice, immunodepletion of BUB1 abolished the spindle checkpoint. Thus, aberrant expression of BUB1 protein could impair mitotic checkpoint function, resulting in aneuploidy, a common phenomenon in gastric cancer. In the present study, an antibody was generated against BUB1 and its expression was studied in gastric cancer tissue sections (n = 80) by immunohistochemistry. Nuclear BUB1 expression was found in all gastric cancer cases. The proportion of tumour cells expressing BUB1 was significantly greater in diffuse-type than in intestinal-type gastric carcinoma (p < 0.001). No correlation was found between BUB1 expression and deoxyribonucleic acid (DNA) ploidy, microsatellite instability or any other histopathological parameters investigated. To the authors' knowledge, this is the first study of BUB1 protein expression in gastric cancer tissues. Different BUB1 protein expression levels in intestinal- and diffuse-type gastric cancer may provide further evidence of a potential link between different genetic pathways and morphological phenotype in gastric carcinogenesis. However, further studies are needed to establish whether there is an association between BUB1 protein expression level and mitotic spindle checkpoint function in gastric cancer.
Copyright 2004 John Wiley & Sons, Ltd.
Similar articles
-
Overexpression of the mitotic checkpoint genes BUB1, BUBR1, and BUB3 in gastric cancer--association with tumour cell proliferation.J Pathol. 2003 May;200(1):16-22. doi: 10.1002/path.1324. J Pathol. 2003. PMID: 12692836
-
Frequent mutations of human Mad2, but not Bub1, in gastric cancers cause defective mitotic spindle checkpoint.Mutat Res. 2005 Oct 15;578(1-2):187-201. doi: 10.1016/j.mrfmmm.2005.05.020. Mutat Res. 2005. PMID: 16112690
-
Genomic instability at the BUB1 locus in colorectal cancer, but not in non-small cell lung cancer.Cancer Res. 2000 Aug 15;60(16):4349-52. Cancer Res. 2000. PMID: 10969775
-
Genetic pathways of two types of gastric cancer.IARC Sci Publ. 2004;(157):327-49. IARC Sci Publ. 2004. PMID: 15055305 Review.
-
Molecular mechanisms involved in the pathogenesis of gastric carcinoma: interactions between genetic alterations, cellular phenotype and cancer histotype.Hepatogastroenterology. 2001 Nov-Dec;48(42):1523-30. Hepatogastroenterology. 2001. PMID: 11813565 Review.
Cited by
-
BUB1 immunolocalization in breast carcinoma: its nuclear localization as a potent prognostic factor of the patients.Horm Cancer. 2013 Apr;4(2):92-102. doi: 10.1007/s12672-012-0130-x. Epub 2013 Jan 4. Horm Cancer. 2013. PMID: 23288590 Free PMC article.
-
Hec1/Ndc80 is overexpressed in human gastric cancer and regulates cell growth.J Gastroenterol. 2014 Mar;49(3):408-18. doi: 10.1007/s00535-013-0809-y. Epub 2013 Apr 17. J Gastroenterol. 2014. PMID: 23591767
-
Key signaling networks are dysregulated in patients with the adipose tissue disorder, lipedema.Int J Obes (Lond). 2022 Mar;46(3):502-514. doi: 10.1038/s41366-021-01002-1. Epub 2021 Nov 11. Int J Obes (Lond). 2022. PMID: 34764426 Free PMC article.
-
BCL6 degradation caused by the interaction with the C-terminus of pro-HB-EGF induces cyclin D2 expression in gastric cancers.Br J Cancer. 2009 Apr 21;100(8):1320-9. doi: 10.1038/sj.bjc.6605010. Epub 2009 Mar 31. Br J Cancer. 2009. PMID: 19337254 Free PMC article.
-
Low BUB1 expression is an adverse prognostic marker in gastric adenocarcinoma.Oncotarget. 2017 Jul 18;8(44):76329-76339. doi: 10.18632/oncotarget.19357. eCollection 2017 Sep 29. Oncotarget. 2017. PMID: 29100315 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical